Bera, Rimal B

Title(s)Health Sciences Professor, Psychiatry and Human Behavior
Phone(714) 456-6898
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lochhead JD, Nelson MA, Bera R. Modafinil associated with new-onset obsessivecompulsive disorder. Ann Clin Psychiatry. 2018 Feb; 30(1):70-71. PMID: 29373621.
      View in: PubMed
    2. Potkin SG, Bera R, Eramo A, Lau G. A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia. Clin Schizophr Relat Psychoses. 2017 Winter; 10(4):211-221. PMID: 24846880.
      View in: PubMed
    3. Bera R, Offord S, Zubek D, Lau G, Lin J, Karson C. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy. J Clin Psychopharmacol. 2014 Feb; 34(1):30-5. PMID: 24135840.
      View in: PubMed
    4. Bera RB. Patient outcomes within schizophrenia treatment: a look at the role of long-acting injectable antipsychotics. J Clin Psychiatry. 2014; 75 Suppl 2:30-3. PMID: 24919169.
      View in: PubMed
    5. Potkin S, Bera R, Zubek D, Lau G. Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia. BMC Psychiatry. 2013 Oct 16; 13:261. PMID: 24131801; PMCID: PMC3819472.
    6. Bera R, Offord S, Zubek D, Lau G, Lin J, Baker RA, Karson C. Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics. J Med Econ. 2013; 16(4):522-8. PMID: 23360177.
      View in: PubMed
    7. Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Ther. 2002 Nov; 24(11):1809-23. PMID: 12501876.
      View in: PubMed
    8. Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. J Clin Psychopharmacol. 2002 Apr; 22(2):121-30. PMID: 11910256.
      View in: PubMed